Kimberly Green, PATH

PATH
More than twenty years' experience in public health management, policy development and research.Leads PATH's global work in HIV/TB and oversees the USAID/PATH Healthy Markets project, leveraging innovation to increase key population access to effective HIV interventions

Presenter Of 9 Presentations

Non-Commercial Satellite

Moderated Panel/Q&A

Non-Commercial Satellite

Opening and introduction

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 3
Non-Commercial Satellite
Non-Commercial Satellite

Panel (Part 1): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Non-Commercial Satellite

LF-LAM technology and testing on the horizon: Panel and panelist introduction

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Panel (Part 2): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Non-Commercial Satellite

Conclusion and call to action: Commitment for scaling LF-LAM

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Oral abstract session

The #Stayhome #Selftest campaign. Rapid pivot of HIV testing services to enable continuity of care in Hanoi, Vietnam during the COVID-19 lock-down

Room
Prime Channel-Live sessions

Moderator Of 4 Sessions

Non-Commercial Satellite

Bringing PrEP closer to home: Why is now the time for differentiated PrEP?

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 4
Date
Mon, Jul 6, 2020
Time
11:00 PM - 11:59 PM
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 3
Date
Sat, Jul 4, 2020
Time
06:00 AM - 07:00 AM
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite
Organizer
World Health Organization (WHO); PATH
Room
Satellite Channel 2
Date
Sat, Jul 4, 2020
Time
06:00 AM - 07:00 AM
Session Description
What's the 2+1+1? In July 2019, the World Health Organization updated its PrEP guidance to include the 4-pill (2+1+1) event-driven (ED)-PrEP dosing regimen for men who have sex with men (MSM). ED-PrEP is as equally efficacious as daily oral PrEP when taken correctly, and provides flexibility and choice to those who may not need a daily pill to protect themselves from HIV. ED-PrEP offers the additional advantage of clear guidance on when to start and stop PrEP, reduced cost to users, and lower drug exposure. This session will highlight first experiences in implementing ED-PrEP in early adopter lower- and middle-income countries, sharing key milestones, lessons learned, and challenges overcome. It will also feature a panel discussion on what can be done to further increase access to ED-PrEP among MSM from the perspectives of policy makers, scientists, advocates, and PrEP users themselves.
Non-Commercial Satellite
Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Date
Thu, Jul 9, 2020
Time
06:00 AM - 07:00 AM
Session Description
Tuberculosis is the leading cause of mortality among persons living with HIV (PLHIV), accounting for a third of AIDS-related deaths in 2019. While estimates suggest that PLHIV are 19 times more likely to contract TB, case-finding among PLHIV remains low with 49% unaware of their coinfection. WHO-recommended LF-LAM facilitates quicker TB diagnosis and initiation on treatment (or TB preventive therapy for those without active TB) among PLHIV, but uptake of this test in high TB/HIV burden countries has been too slow. In this session, we will explore barriers to TB diagnosis among PLHIV, spotlight successful adoptions of LF-LAM, highlight results from existing LF-LAM, and preview other diagnostic tools in the pipeline. The session will also include a panel discussion outlining what needs to be done to accelerate access to appropriate tests and treatments to reduce TB-related deaths among PLHIV.

Presenter Of 5 Presentations

Oral abstract session

OAD0603 - Trans-forming PrEP in Vietnam: Rethinking service delivery to enhance access among transgender women

Room
Abstract Sessions On-Demand Channel
Oral abstract session

OADLB0105 - The #Stayhome #Selftest campaign. Rapid pivot of HIV testing services to enable continuity of care in Hanoi, Vietnam during the COVID-19 lock-down

Room
Prime Channel-Live sessions
Oral abstract session

OAE0801 - Introduction

Oral abstract session

OAE0807 - Conclusion

E-Posters

PEC0601 - Decentralized PrEP delivery in Vietnam: High persistence among men who have sex with men and transgender women at month twelve, and strong preference for community clinic setting

Session Name
E-posters Track C
Room
Poster Channel - Track C

Moderator Of 1 Session

Oral abstract session

Presenter Of 1 Presentation

Non-Commercial Satellite

Opening and speaker introduction

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel

Moderator Of 1 Session

Non-Commercial Satellite
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!

Presenter Of 3 Presentations

Oral abstract session

Trans-forming PrEP in Vietnam: Rethinking service delivery to enhance access among transgender women

Room
Abstract Sessions On-Demand Channel
Oral abstract session

Introduction

Oral abstract session

Conclusion

Moderator Of 1 Session

Oral abstract session

Presenter Of 14 Presentations

Non-Commercial Satellite

Opening and introduction

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 3
Non-Commercial Satellite

Opening and speaker introduction

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Non-Commercial Satellite
Non-Commercial Satellite

LF-LAM technology and testing on the horizon: Panel and panelist introduction

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Panel (Part 1): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Non-Commercial Satellite

Conclusion and call to action: Commitment for scaling LF-LAM

Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Non-Commercial Satellite

Panel (Part 2): Why offering ED-PrEP matters, how to accelerate access to ED-PrEP, and where the science is headed!

Non-Commercial Satellite

Moderated Panel/Q&A

Oral abstract session

Trans-forming PrEP in Vietnam: Rethinking service delivery to enhance access among transgender women

Room
Abstract Sessions On-Demand Channel
Oral abstract session

The #Stayhome #Selftest campaign. Rapid pivot of HIV testing services to enable continuity of care in Hanoi, Vietnam during the COVID-19 lock-down

Room
Prime Channel-Live sessions
Oral abstract session

Introduction

Oral abstract session

Conclusion

E-Posters

Decentralized PrEP delivery in Vietnam: High persistence among men who have sex with men and transgender women at month twelve, and strong preference for community clinic setting

Session Name
E-posters Track C
Room
Poster Channel - Track C

Moderator Of 6 Sessions

Oral abstract session
Non-Commercial Satellite
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite - On-demand Channel
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite

Bringing PrEP closer to home: Why is now the time for differentiated PrEP?

Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 4
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite
Organizer
AIDS Vaccine Advocacy Coalition (AVAC); PATH; International AIDS Society (IAS)
Room
Satellite Channel 3
Session Description
The global UNAIDS target is 3 million active PrEP users by the end of 2020 but as of June there were only an estimated 575,000 enrolled. Despite slow roll-out initially, there are now at least 78 countries offering PrEP but with less diversity in service models than seen in differentiated ART delivery. Pre-COVID-19, there was a move towards more community-based or virtual/Telehealth models that have since been accelerated during COVID-19 country lock-downs. In this session, we will highlight how some countries have rapidly pivoted PrEP programming be more differentiated and truly client-centered—offering online, community, and private-sector service options to expand and maintain access. In the live session, perspectives from providers, PrEP users, ministry of health, and global normative agencies will also be shared with a moderated discussion on how a differentiated approach to PrEP will be essential to significantly increase uptake by the end of 2020 and beyond!
Non-Commercial Satellite
Organizer
World Health Organization (WHO); PATH
Room
Satellite Channel 2
Session Description
What's the 2+1+1? In July 2019, the World Health Organization updated its PrEP guidance to include the 4-pill (2+1+1) event-driven (ED)-PrEP dosing regimen for men who have sex with men (MSM). ED-PrEP is as equally efficacious as daily oral PrEP when taken correctly, and provides flexibility and choice to those who may not need a daily pill to protect themselves from HIV. ED-PrEP offers the additional advantage of clear guidance on when to start and stop PrEP, reduced cost to users, and lower drug exposure. This session will highlight first experiences in implementing ED-PrEP in early adopter lower- and middle-income countries, sharing key milestones, lessons learned, and challenges overcome. It will also feature a panel discussion on what can be done to further increase access to ED-PrEP among MSM from the perspectives of policy makers, scientists, advocates, and PrEP users themselves.
Non-Commercial Satellite
Organizer
PATH; Stop TB Partnership; Stop TB Partnership Private Sector Constituency
Room
Satellite Channel 2
Session Description
Tuberculosis is the leading cause of mortality among persons living with HIV (PLHIV), accounting for a third of AIDS-related deaths in 2019. While estimates suggest that PLHIV are 19 times more likely to contract TB, case-finding among PLHIV remains low with 49% unaware of their coinfection. WHO-recommended LF-LAM facilitates quicker TB diagnosis and initiation on treatment (or TB preventive therapy for those without active TB) among PLHIV, but uptake of this test in high TB/HIV burden countries has been too slow. In this session, we will explore barriers to TB diagnosis among PLHIV, spotlight successful adoptions of LF-LAM, highlight results from existing LF-LAM, and preview other diagnostic tools in the pipeline. The session will also include a panel discussion outlining what needs to be done to accelerate access to appropriate tests and treatments to reduce TB-related deaths among PLHIV.